Inozyme Pharma, Inc. - Common stock, par value $0.0001 per share (INZY)

Historical Holders from Q3 2020 to Q3 2025

Symbol
INZY
CUSIP
45790W108
Type / Class
Equity / Common stock, par value $0.0001 per share
Shares outstanding
64.5M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
0
Holdings value
$0
Grand Portfolio weight change
0%
Number of holders
0
Number of sells
-85
Average Value change %
0%
Average sells %
-0.004%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Inozyme Pharma, Inc. - Common stock, par value $0.0001 per share (INZY)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
GLAZER CAPITAL, LLC 6.59% $17M 4.25M Glazer Capital, LLC May 28, 2025
BlackRock, Inc. 4.1% $3.14M 2.66M BlackRock, Inc. Jun 30, 2025
EVENTIDE ASSET MANAGEMENT, LLC 3.46% $1.82M 2.22M Eventide Asset Management, LLC Dec 31, 2024
Affinity Asset Advisors, LLC 2.89% $2.2M 1.87M Affinity Healthcare Fund, LP May 20, 2025

Institutional Holders of Inozyme Pharma, Inc. - Common stock, par value $0.0001 per share (INZY)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 0 $0 -$202M 0
2025 Q2 50.6M $202M +$62.7M $4.00 86
2025 Q1 46.7M $42.5M -$10.9M $0.91 97
2024 Q4 52.4M $145M -$16.3M $2.77 103
2024 Q3 54.6M $286M +$3.38M $5.23 88
2024 Q2 53.8M $240M +$13M $4.46 89
2024 Q1 49.9M $382M +$1.44M $7.66 87
2023 Q4 57.9K $247K +$64.3K $4.26 2
2023 Q3 48.7M $205M +$58.1M $4.20 77
2023 Q2 34.1M $190M +$12M $5.57 72
2023 Q1 32M $183M +$30.2M $5.73 49
2022 Q4 28.9M $30.4M -$8.2M $1.05 35
2022 Q3 30.8M $82.7M -$2.25M $2.68 36
2022 Q2 31.5M $149M +$68.5M $4.77 38
2022 Q1 17.4M $71.2M -$1.91M $4.09 47
2021 Q4 17.3M $118M -$3.8M $6.82 48
2021 Q3 17.5M $202M -$48.7M $11.59 48
2021 Q2 19.8M $337M +$9.95M $17.04 50
2021 Q1 19.2M $379M +$15.5M $19.80 55
2020 Q4 18.4M $379M +$7.77M $20.64 53
2020 Q3 16.3M $429M +$429M $26.29 52